Atara Biotherapeutics, Inc. (ATRA) Social Stream
ATARA BIOTHERAPEUTICS INC (ATRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ATARA BIOTHERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 7 | $31 | $26 | $27.8 | $4.82 | 476.76% |
| 2021-12-09 | 7 | $31 | $26 | $28 | $4.82 | 480.91% |
| 2021-12-13 | 6 | $31 | $26 | $28 | $4.82 | 480.91% |
| 2021-12-15 | 5 | $31 | $24 | $27.25 | $4.82 | 465.35% |
| 2022-01-24 | 5 | $31 | $24 | $27.5 | $4.82 | 470.54% |
| 2022-01-26 | 5 | $31 | $25 | $27.75 | $4.82 | 475.73% |
| 2022-02-23 | 5 | $31 | $25 | $27 | $4.82 | 460.17% |
| 2022-03-01 | 5 | $31 | $20 | $25.75 | $4.82 | 434.23% |
| 2022-05-05 | 5 | $31 | $20 | $24.5 | $4.82 | 408.3% |
| 2022-05-12 | 5 | $31 | $8 | $20.8 | $4.82 | 331.54% |
| 2022-05-23 | 6 | $29 | $8 | $20.4 | $4.82 | 323.24% |
| 2022-05-24 | 7 | $29 | $4 | $17.333 | $4.82 | 259.61% |
| 2022-07-25 | 7 | $50 | $3 | $17.857 | $4.82 | 270.48% |
| 2022-08-09 | 7 | $50 | $3 | $17.757 | $4.82 | 268.4% |
| 2022-08-15 | 8 | $50 | $3 | $17.042 | $4.82 | 253.57% |
| 2022-11-09 | 8 | $50 | $3 | $18.787 | $4.82 | 289.77% |
| 2022-11-15 | 8 | $50 | $3 | $18.75 | $4.82 | 289% |
| 2023-01-05 | 9 | $50 | $3 | $19.444 | $4.82 | 303.4% |
The Trend in the Analyst Price Target
Over the past 44 weeks, ATRA's average price target has gone down $6.88.
ATRA reports an average of 286.21% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-04 | 5 | 31 | 25 | 27.000 | 14.61 | 84.8% |
| 2022-05-05 | 4 | 31 | 20 | 24.500 | 6.82 | 259.24% |
| 2022-08-18 | 8 | 50 | 3 | 18.787 | 4.74 | 296.35% |
| 2022-11-09 | 8 | 50 | 3 | 18.750 | 3.88 | 383.25% |
| 2023-01-05 | 9 | 50 | 3 | 19.444 | 3.56 | 446.18% |
ATRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 4 | 0 | 2 | 2 | 2 | 8 |
The Trend in the Broker Recommendations
ATRA's average broker recommendation rating improved by 0 over the prior 153 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATRA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ATARA BIOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2091.66% of them.
- In terms of how ATARA BIOTHERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1352.43% of that group.
- ATARA BIOTHERAPEUTICS INC's number of analysts covering the stock is greater than 1729.8% of stocks in the small market cap category.
- ATARA BIOTHERAPEUTICS INC's average analyst price target is higher than 907.76% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ATARA BIOTHERAPEUTICS INC are CGEN, ONVO, and XTNT.
View All Top Stocks by Price Target
Is ATRA a Buy, Hold or Sell? See the POWR Ratings now!